Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours

Oncogene

Volumn 15, Issue 17, 1997, Pages 2031-2035

  Roy Jr , William J ^a   Watson, Richard H ^a   Hitchcock, Andrew ^a   Campbell, Ian G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Benign; Chromosome 6, 7, 9, 11 and 17; Loss of heterozygosity; Microsatellite; Ovarian tumours; PCR; Tumour suppressor genes

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 9P; CODON; EPITHELIUM TUMOR; FEMALE; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; OVARY TUMOR; POINT MUTATION; PRIORITY JOURNAL; TUMOR BIOPSY;

EID: 9844247563     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201372     Document Type: Article

References (21)

1. Berchuck A, Kohler MF, Hopkins MP, Humphrey PA, Robboy SJ, Rodriguez GC, Soper JT, Clarkepearson DL and Bast RC. (1994). Gynecologic Oncol., 52, 232-236.
2. Campbell IG, Beynon G, Davis M and Englefield P. (1995). Int. J. Cancer, 63, 222-225.
3. Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC, Solomon E, Trowsdale J and Black DM. (1994). Hum. Mol. Genet., 3, 589-594.
4. Chenevix-Trench G, Kerr J, Friedlander M, Hurst T, Sanderson B, Coglan M, Ward B, Leary J and Khoo SK. (1994). Am. J. Hum. Genet., 55, 143-149.
5. Collins A, Frezal J, Teague J and Morton NE. (1996). Proc. Natl. Acad. Sci. USA, 93, 14771-14775.
6. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 4456-4460.
7. Englefield P, Foulkes WD and Campbell IG. (1994). Br. J. Cancer, 70, 905-907.
8. Fearon ER and Vogelstein BA. (1990). Cell, 61, 759-767.
9. Foulkes W, Ragoussis J, Stamp GW, Allan GJ and Trowsdale J. (1993). Br. J. Cancer, 67, 551-559.
10. Foulkes WD, Stamp GWH, Afzal S, Lalani N, McFarlane CP, Trowsdale J and Campbell IG. (1995). Br. J. Cancer, 72, 883-888.
11. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RCF, Steel CM, Porteous DJ and Smyth JF. (1996). Cancer Res., 56, 950-954.
12. Kerr J, Leary JA, Hurst T, Shih YC, Antalis TM, Friedlander M, Crawford E, Khoo SK, Ward BRCAl and Chenevix-trench G. (1996). Oncogene, 13, 1815-1818.
13. Kim JW, Cho YH, Kwon DJ, Kim TE, Park TC, Lee JM and Namkoong SE. (1995). Gynecologic Oncol., 57, 199-204.
14. Milner BRCAl J, Allan LA, Eccles DM, Kitchener HC, Leonard RCF, Kelly KF, Parkin DE and Haites NE. (1993). Cancer Res., 53, 2128-2132.
15. Orphanos V, McGown G, Hey Y, Thorncroft M, Santibanezkoref M, Russell SEH, Hickey I, Atkinson RJ and Boyle JM. (1995). Br. J. Cancer, 77, 666-669.
16. Puls LE, Powell DE, Depriest PD, Gallion HH, Hunter JE, Kryscio RJ and Vannagell JR. (1992). Gynecologic Oncol., 47, 53-57.
17. Salazar H, Godwin AK, Daly M BRCAl, Laub P BRCAl, Hogan WM, Rosenblum N, Boente MP, Lynch HT and Hamilton TC. (1996). J. Natl. Cancer Inst., 88, 1810-1820.
18. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC and Godwin AK. (1995). Cancer Res., 55, 2150-2157.
19. Zenklusen JC, Weitzel JN, Ball HG and Conti CJ. (1995). Oncogene, 359-363.
20. Zheng JP, Benedict WF, Xu HJ, Hu SX, Kim TM, Velicescu M, Wan MH, Cofer KF and Dubeau L. (1995). J. Natl. Cancer Inst., 87 1146-1153.
21. Zheng JP, Wan MH, Zweizig S, Velicescu M, Yu MC and Dubeau L. (1993). Cancer Res., 53, 4138-4142.